Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...

Prostate cancer is the leading cancer type in men. Getting screened can help you catch cancer early, when it’s easier to ...

Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...

The "Man Van" reached almost 3,500 men, 85% of whom showed up for scheduled screening exams. Almost 100 prostate cancers were ...

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

But there is a dearth of prospective data on the predictive value of PSA levels below this threshold. To analyse the prevalence of prostate cancer in men with a serum PSA level ≤4.0 ng/ml.

In the next in our series, GP Dr Roger Henderson debunks common myths about prostate cancer – and highlights some less ...

DHA chief executive, Ryl Jensen, says the PSA is right to be worried. The risks are very real, and these cuts could ultimately have severe consequences for the country’s health system.

Velavan Senthilkumar expressed his happiness and gratitude for having emerged from a long and challenging week with both the ...